Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 12
Submit an article Journal homepage
112
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Are Activation Markers (CD25, CD38 and CD103) Predictive of Sensitivity to Purine Analogues in Patients with T-cell Prolymphocytic Leukemia and other Lymphoproliferative Disorders?

Julio Delgado Department of Hematology, Hospital Universitario La Paz, Planta 6 a Diagonal, Paseo Castellana 261, 28046 Madrid, Spain
,
Jesus G. Bustos Department of Hematology, Hospital Universitario La Paz, Planta 6 a Diagonal, Paseo Castellana 261, 28046 Madrid, Spain
,
Ma Carmen Jimenez Department of Hematology, Hospital Universitario La Paz, Planta 6 a Diagonal, Paseo Castellana 261, 28046 Madrid, Spain
,
Evaristo Quevedo Department of Hematology, Hospital Universitario La Paz, Planta 6 a Diagonal, Paseo Castellana 261, 28046 Madrid, Spain
&
Fernando Hernandez-Navarro Department of Hematology, Hospital Universitario La Paz, Planta 6 a Diagonal, Paseo Castellana 261, 28046 Madrid, Spain; Department of Medicine, Universidad Autonoma de Madrid, Madrid, Spain
Pages 2331-2334 | Published online: 01 Jul 2009

  • Matutes, E. Brito-Babapulle, V., Swansbury, J., Ellis, J., Morilla, R., Dearden, C., Sempere, A. and Calovsky, D. (1991) "Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia", Blood 78, 3269-3274.
  • Garand, R., Goasguen, J., Brizard, A., Buisine, J., Charpentier, A., Claisse, J.F. Duchayne, E., Lagrange, M., Segonds, C., Troussard, X. and Flandrin, O. (1998) "Indolent course as a relatively frequent presentation in T-prolymphoeytic leukaemia", British Journal of Haematology 103, 488-494.
  • Mereieca, J., Matutes, E., Dearden, C., MacLeinwn, K. and Catovsky, D. (1974) "The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype". Journal of Clinical Oncology 12, 2588-2593.
  • Dearden, C.E., Matutes, E., Cazin, B., Tjonnfjord, O.E., Parrcira, A., Nomdedeu, B., Leoni, P. Clark, F.J., Radia, D., Rassam, S.M., Roques, T., Kettear, N., Brito-Babapulle, V., Dyer, M.J. and Catovsky, D. (2001) "High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H". Blood 98, 1721-1726."
  • Erber, W.N. and Mason, D.Y. (1988) "Expression of the interleukin-2 receplor (Tac antigen/CD25) in hematologic neoplasms", American Journal of Clinical Pathology 89, 645-648.
  • Lenkei, R., Bratt, G., Holmberg, V., Muirhead, K. and Sandstrom, E. (1998) "Indicators of T-cell activation: correlation between quantitative CD38 expression and soluble CD8 levels in asymptomatic HIV+ individuals and healthy controls", Cytometry 33, 115-122.
  • Funaro, A., Morra, M, Calosso, L., Zini, M.G., Ausiello, CM. and Malavasi, F. 11997) "Role of the human CD38 molecule in B cell activation and proliferation". 'Tissue Antigens 49, 7-15.
  • Hamblin, T.J., Orchard, J.A., lbbotson, R.E., Davis, Z., Thomas, P.W., Stevenson, KK. and Oscier, D.G. (2002) "CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease". Blood 99, 1023-1029.
  • Mulligan, K.P., Travade, P., Matutes, E., Dearden, C., Visser, L., Poppema., S. and Catovsky, D. (1990) "B-ly-7. a monoclonal antibody reactive with hairy cell leukemia, also defines an activation antigen on normal CD8+ T cells", Blood 76, 959-964.
  • Micklem, K.J., Dong, Y., Willis, A., PuIford, K.A., Visser, L., Durkop, H., Poppema, S., Stein, H. and Mason, D.Y. (1991) "HML-I antigen on mucosa-associated T celts, activated cells, and hairy leukemic cells is a new integrin containing the beta 7 subunit"., American Journal of Pathology 139, 1297-1301l.
  • Dietz., S.B. Whitaker-Menezes., D, and Lenson, S.R. (1996) "The role of alphaE beta? integrin (CD103) and E-cadherin in epidermotropism in cutaneous T-cell lymphoma". Journal of Cutaneous Pathology 23, 312-318.
  • Katoh, A., Ohshima, K, Kanda, M., Huraoka, S, Sugihura, M., Suzumiya, J., Kawasaki., G., Shimazaki, K, Ikeda, S. and Kikufcuchi., M. (2000) "Gastruointestinal T cell Iymphoma: predominant cytoxic phenolypes. including alpha/beta. gamma/delta T cell and natural killer cell". Leukemia and Lymphoma 39, 97-111.
  • Pettitt, A.R., Zuzel, M. and CawIey, J.C. (1999) "Hairy-cell leukaemia biology and management". British Journal of Haematology 106, 2-8.
  • Wollner, N., Burchenal, J.H. Liberman, P.M., Execlby., P., D'Angio, G. and Murphy, M.L. (1976) "Non-Hodpkin's Iyvmiphoma in children. A comparative study of two modalilties of therapy". Cancer 37, 123
  • Johnson, S.A. and Thomas, W. (2000) "Therapeutic potential of purine analogue combinations in the treatment of lymphoid malignancies". Hematological Oncology 18, 141-153.
  • Saven, A, and Piro, L.D. (1994) "Newer purine analogues for the treatment of hairy-cell leukemia". New England Journal of Medicine 330, 691-697.
  • Kurzrock, R., Pilat., S. and Duvicm, M. (1999) " "Pentostatin therapy of T-eell lymphomas with cutaneous manifestations. Journal of Clinical Oncology, 17, 317- 3121.
  • Robak, T. (2002) "The rule of nucleoside analogues in the treatment of chronic lymphocytic Leukemia-lessons learned from prospective randomized trials". Leukemia and Lymphoma 43, 537-548.
  • Muhammad, R.M., Katato, K., Almatchy, V.P., Wall, N, Liu, K.Z., Schultz., C P. Mantsch, H.H., Varterasian, M. and al-Katib, A.M. (1998) "Sequential treatment of human chronic lymphocytic leukemia with bryustatin 1 followed by 3-chlorodeoxya-denosine: preclinical studies". Clinical Cancer Research 4, 445-453.
  • Ahmad !., AI-KaTib, A.M., BECK., RW. and Mohamad., R.M. (2000) "Seqemental treatment ol' a resistant chronic lympliocylie leakenia patient with bryostain 1 follwed by 2-chlorndeoxyadenosine: case report". Clinical Canrer Research 6, 1328-1332.
  • Hanson, C.A., Ward, P.C. and. Schnitzer, B. (1989) "A multiobular variatuuni of hairy cell Ieukemia with morphologic siinilarities to T-cell lymphoma", American Journal Surgical Patholiogy 13, 671-669.
  • Visser, L. and Poppema, S. (1990) "Induction of B-cell chronic lyinphccytic leukaemia and hairy cell leukaemia like phenotyypes. by phorbol ester treatment of normal peripheral blond B-cells". Bri9tish Journal of Haematology, 75, 359-365.
  • Nair, CN., Shindc, S., Kumar, E., Goyal, R., Nadkarni, K.S and Advani, S.U. (1999) "Sezary cells with hairy projections.". Leukemia Research 23, 195-147
  • Dianiandidou, E., Cohen, P.R. and Kurzrock, R. (1996) "Mycosis fungoides and Sezary syndrome". Blood 88, 2385-2409.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.